Multiplex spatial biology technologies have transformed biomedical research by enabling high-plex molecular profiling while preserving tissue architecture and spatial context. As new discoveries emerge, biomarker panels must evolve alongside the science. This webinar explores a streamlined solution to rapidly and reproducibly build custom multiplex proteomic biomarker panels.
While expertly designed off-the-shelf panels provide a strong foundation for many applications, researchers increasingly need the flexibility to tailor and expand panels to address new hypotheses, incorporate emerging biomarkers, and scale between unbiased discovery and targeted validation.
In this webinar, our featured speakers will introduce a user-friendly workflow for developing custom multiplex proteomic biomarker panels using next-generation molecular barcoding technology. They will discuss best practices for custom panel design and explore how researchers can rapidly and reproducibly tailor existing assays or build de novo panels without compromising performance.
Register to learn how a streamlined molecular barcoding workflow enables flexible custom panel development for spatial proteomics, empowering researchers to build, expand, and adapt assays for evolving research questions and multi-omic spatial biology analyses.
Speakers
Antoinette Ronquillo, MS, Senior Field Application Scientist, Quanterix®
Antoinette brings more than six years of experience in spatial proteomics, including hands-on experience with the Akoya PhenoCycler-Fusion, PhenoImager HT and other legacy platforms. She supports advanced spatial biology technologies across dozens of academic, biopharma and CRO accounts throughout Western North America. With deep expertise in multiplex immunofluorescence assay development, tissue-based imaging and antibody-based spatial workflows, she leads instrument trainings, technical seminars and early-access programs that accelerate the adoption of cutting-edge spatial platforms.
Message Presenter
Clemens Duerrschmid, PhD, Senior Manager, Field Applications, Quanterix®
Dr. Clemens Duerrschmid is a biotechnology professional with expertise in imaging, single-cell biology and spatial proteomics. He currently leads the Field Applications Scientist team at Quanterix, where he focuses on technical strategy, customer education and adoption of spatial biology and immunoassay platforms.
With more than a decade of experience spanning academia, biotech and pharma, Clemens has supported scientific discovery through technology and collaboration. Prior to Quanterix, he held leadership and customer-facing roles at Akoya Biosciences, where he worked with key opinion leaders, represented spatial biology at seminars and conference presentations and supported researchers across multiple fields. His earlier research career included developing immunoassays and studying metabolic disease therapeutics as a Postdoctoral Fellow at Baylor College of Medicine and Case Western Reserve University.
Clemens holds a PhD in Biotechnology from BOKU University in Vienna, Austria. He is committed to helping researchers advance discovery in spatial biology and liquid biomarker research.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Discovery, Translational, and Clinical Researchers
- Pharmaceutical and biotechnology R&D teams
- Clinical Development leaders and Clinical Trial teams
- Translational Scientists and Biomarker Strategy Leads
- Clinical Operations professionals focused on trial design and execution
- Precision Medicine and Diagnostics leaders leveraging biomarker insights
What You Will Learn
- How next-generation molecular barcoding compares with conventional antibody conjugation approaches
- How molecular barcoding enables flexible custom panel development and supports multi-omic spatial analyses
- Best practices for designing de novo biomarker panels or expanding existing assays using a streamlined, reproducible workflow
- Explore resources to support the design, implementation, and analysis of custom spatial proteomic studies
Xtalks Partner
Quanterix
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at www.quanterix.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account